Allelic Loss and the Progression of Breast Cancer

Cancer Research

Volumn 55, Issue 22, 1995, Pages 5180-5183

  Radford, Diane M ^a   Fair, Keri L ^a   Holt, Matthew ^a   Donis Keller, Helen ^a   Ritter, Jon H ^a   Phillips, Nancy J ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11P; CHROMOSOME DELETION; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INFILTRATING DUCT; CHROMOSOME DELETION; FEMALE; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028792410     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fearon, E. R., and Jones, P. A. Progressing towards a molecular description of colorectal cancer development. FASEB J., 6:2783–2790, 1992.
2. Rogers, L. W. Carcinoma in situ (CIS). In:D. L. Page and T. J. Anderson (eds.), Diagnostic Histopathology of the Breast, pp. 157–192. Edinburgh:Churchill Livingstone, 1987.
3. Radford, D. M., Fair, K., Thompson, A. M., Ritter, J. H., Holt, M. S., Wallace, M. W., Wells, S. A., Jr., and Donis-Keller, H. R. Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res., 53:2947–2950, 1993.
4. Radford, D. M., Fair, K. L., Thompson, A. M., Ritter, J. H., Holt, M. S., Wells, S. A., and Donis-Keller, H. R. Chromosomal regions implicated in the development of breast cancer. Surg. Forum, 44:502–504, 1993.
5. Radford, D. M., Fair, K. L., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., and Donis-Keller, H. R. Allelotyping of ductal carcinoma in situ (DCIS) of the breast:deletion of loci on 8p, 13q, 16q, 17p, and 17q. Cancer Res., 55:3399–3405, 1995.
6. Zhuang, Z., Merino, M. J., Chuaqui, R., Liotta, L., and Emmert-Buck, M. R. Identical allelic loss on chromosome llql3 in microdissected in situ and invasive breast cancer. Cancer Res., 55:467–471, 1995.
7. O'Connell, P., Pekkel, V., Fuqua, S., Osborne, C. K., and Allred, D. C. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res. Treat., 32:5–12, 1994.
8. Devilee, P., van Vliet, M., van Sloun, P., Kuipers-Dijkshoorn, N., Hermans, J., Pearson, P. L., and Cornelisse, C. J. Allelotype of human breast carcinoma:a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6:1705–1711, 1991.
9. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer:cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50:7184–7189, 1990.
10. Alpers, C. E., and Wellings, S. R. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum. Pathol., 16:796–807, 1985.
11. Dupont, W. E., and Page, D. L. Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 312:146–151, 1985.
12. Solin, L. J., Recht, A., Fourquet, A., Kurtz, J., Kuske, R., McNeese, M., McCormick, B., Cross, M. A., Schultz, D. J., Bornstein, B. A., Spitalier, J.-M., Vilcoq, J. R., Fowble, B. L., Harris, J. R., and Goodman, R. L. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer (Phila.), 68:2337–2344, 1991.
13. Davidoff, A. M., Kerns, B., Iglehart, J. D., and Marks, J. R. Maintenance of p53 alterations throughout breast cancer progression Cancer Res., 51:2605–2610, 1991.
14. Maguire, H. C., Jr., Hellman, M. E., Greene, M. I., and Yeh, I. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinoma of the female breast. Pathobiology, 60:117–121, 1992.
15. Watson, P. H., Safneck, J. R., Le, K., Dubik, D., and Shiu, R. P. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and metastasis. J Natl. Cancer Inst., 85:902–907, 1993.
16. Nowell, P. The clonal evolution of tumor cell populations. Science (Washington DC), 194:23–28, 1976.
17. Mackay, J., Elder, P. A., Porteous, D. J., Steel, C. M., Hawkins, R. A., Going, J. J., and Chetty, U. Partial deletion of chromosome lip in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br. J. Cancer, 58:710–714, 1988.
18. Takika, K., Sato, T., Miyagi, M., Watatani, M., Akiyama, F., Sakamoto, G., Kasumi, F., Abe, R., and Nakamura, Y. Correlation of loss of alleles on the short arm of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res., 52:3914–3917, 1992.
19. Borg, A., Zhang, Q., Olsson, H., and Wengren, E. Chromosome 1 alterations in breast cancer:allelic loss on lp and lq is related to lymphogenic metastases and poor prognosis. Genes Chromosomes & Cancer, 5:311–320, 1992.
20. Bieche, I., Champeme, M. H., Matifas, F., Hacene, K., Callahan, R., and Lidereau, R. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet, 339:139–143, 1992.